Economic Evaluations of Mindfulness-Based Interventions: a Systematic Review.
Lingling Zhang, Snehal Lopes, Tara Lavelle, Karyn Ogata Jones, Liwei Chen, Meenu Jindal, Heidi Zinzow, Lu Shi
Mindfulness January 1, 2022 DOI: 10.1007/s12671-022-01960-1 (opens in new tab) via PubMed
Summary
AI-generated from the abstractA systematic review of 28 cost-effectiveness and cost-benefit analyses of mindfulness-based interventions (MBIs) published between 1985 and 2021 found that standardized programs such as mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT) are less costly and more effective than usual care or cognitive behavioral therapy for several patient populations. MBSR was associated with lower healthcare costs and better outcomes for chronic lower back pain, fibromyalgia, and breast cancer. MBCT showed cost-effectiveness advantages for depression, medically unexplained symptoms, multiple sclerosis, breast cancer with persistent pain, adults with a history of major depressive episodes, ADHD, and all cancer patients. Mindfulness training also reduced costs from a societal perspective when used for aggressive behaviors in people with intellectual or developmental disabilities in mental health facilities.
Study at a glance
| Characteristics | Systematic review Qualitative Peer reviewed |
|---|---|
| Sample size | 28 |
| Population | Studies of mindfulness-based interventions |
| Interventions | Mindfulness-based stress reduction Mindfulness-based cognitive therapy |
| Topics | Meditation |
| Keywords | Cost-effectiveness analysis |
| Key finding | Standardized mindfulness-based interventions (MBSR and MBCT) are less costly and more effective than usual care or cognitive behavioral therapy for various patient populations. |
Abstract
This study includes a systematic review of cost-effectiveness analyses (CEAs) and cost-benefit analyses (CBAs) of mindfulness-based interventions (MBIs). A literature search was conducted using PubMed, Web of Science, JSTOR, and CINAHL for studies published between January 1985 and September 2021, including an original cost-related evaluation of an MBI. A qualitative assessment of bias was performed using the Drummond checklist. Twenty-eight mindfulness-based intervention studies (18 CEAs and 10 CBAs) were included in this review. Mindfulness-based stress reduction (MBSR) was less costly and more effective when compared with the usual care of cognitive behavioral therapy among patients with chronic lower back pain, fibromyalgia, and breast cancer. MBSR among patients with various physical/mental conditions was associated with reductions in healthcare costs. Mindfulness-based cognitive therapy (MBCT) was also less costly and more effective than the comparison group among patients with depression, medically unexplained symptoms, and multiple sclerosis. MBCT's cost-effectiveness advantage was also identified among breast cancer patients with persistent pain, non-depressed adults with a history of major depressive disorder episodes, adults diagnosed with ADHD, and all cancer patients. From a societal perspective, the cost-saving property of mindfulness training was evident when used as the treatment of aggressive behaviors among persons with intellectual/developmental disabilities in mental health facilities. Based on this review, more standardized MBI protocols such as MBSR and MBCT compare favorably with usual care in terms of health outcomes and cost-effectiveness. Other MBIs may result in cost savings from both healthcare and societal perspectives among high-risk patient populations.